Your browser doesn't support javascript.
loading
Combining PARP inhibitors and platinum-based chemotherapy in metastatic triple negative and/or BRCA-associated breast cancer.
Molto Valiente, Consolacion; Amir, Eitan.
Affiliation
  • Molto Valiente C; Division of Medical Oncology and Hematology, Department of Medicine, Princess Margaret Cancer Centre and University of Toronto, Toronto, ON, Canada.
  • Amir E; Division of Medical Oncology and Hematology, Department of Medicine, Princess Margaret Cancer Centre and University of Toronto, Toronto, ON, Canada.
Transl Cancer Res ; 12(7): 1887-1890, 2023 Jul 31.
Article in En | MEDLINE | ID: mdl-37588734
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Risk_factors_studies Language: En Journal: Transl Cancer Res Year: 2023 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Risk_factors_studies Language: En Journal: Transl Cancer Res Year: 2023 Document type: Article Affiliation country: Country of publication: